Frazier Lifesciences Acquisition Corp. (FLAC) Shareholders Approve NewAmsterdam Pharma Deal

Frazier Lifesciences (NASDAQ:FLAC) announced this morning that its shareholders have approved its business combination with biotech firm NewAmsterdam Pharma Holding during a special meeting today.

The SPAC disclosed that holders of approximately 32% of FLAC Class A ordinary shares exercised their right to redeem their shares for cash, significantly lower than the average redemption rate for completed deals this year at 83.99%. ...READ MORE

Kingswood Acquisition Corp. (KWAC) Adjourns Extension Vote

Kingswood Acquisition Corp. (NYSE:KWAC) announced this morning that it is adjourning tomorrow’s special meeting from November 15, to November 18.

Similar to the issues Digital World (Nasdaq: DWAC) is having with its own extension vote, Kingswood disclosed that the meeting is being adjourned in order to solicit more votes toward the approval to further extend to May 24, 2023. ...READ MORE

East Stone Acquisition Corp. (ESSC) Shareholders Approve ICONIQ Deal

East Stone (NASDAQ:ESSC) announced this morning that its shareholders have approved its business combination with EV-maker ICONIQ during a special meeting held on November 10.

The special meeting was originally scheduled for November 7, but was later adjourned to November 8, and then adjourned once again to November 10. ...READ MORE

8i Acquisition 2 Corp. (LAX) Shareholders Approve EUDA Health Deal

8i Acquisition 2 (NASDAQ:LAX) announced this afternoon that its shareholders have approved its combination with digital health firm EUDA at a special meeting this morning.

As of November 8, the SPAC saw a total of 8,195,770 ordinary shares tendered for redemption resulting in the final redemption price of $10.0837 per share. ...READ MORE

Vickers Vantage Corp. I (VCKA) Shareholders Approve Scilex Deal

Vickers Vantage Corp. I (NASDAQ: VCKA) announced this afternoon that its shareholders have approved its combination with commercial biopharmaceutical company Scilex, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), at a special meeting held yesterday, November 9. ...READ MORE

AGBA Acquisition Limited (AGBA) Shareholders Approve TAG Deal

AGBA Acquisition Limited (NASDAQ:AGBA) announced this morning that its shareholders have approved its combination with the five subsidiaries of financial holding company TAG.

The SPAC disclosed that a total of 3,339,229 shares were tendered for redemption in connection the special meeting of shareholders. But, ...READ MORE